New Study to Address Cancer Treatment Resistance for People Who Are KRAS Positive

2022-11-30T09:45:01-06:00November 30th, 2022|Hot Topics, News, Science and Research|

SAN CARLOS, Calif., (November 30, 2022) – The Addario Lung Cancer Medical Institute (ALCMI), a patient-founded not-for-profit global research consortium, has launched the SPARK Study to help researchers better understand treatment resistance in patients with KRAS-positive lung cancer and [...]

Go to Top